Foresight Biotherapeutics' Unattributed - II Round

Foresight Biotherapeutics raised a round of funding on November 13, 2013.

Foresight Biotherapeutics is a clinical-stage drug development company developing therapies designed to address unmet needs in ophthalmology and otolaryngology. Foresight's platform Povidone-Iodine (P…

Articles about Foresight Biotherapeutics' Unattributed - II Round: